nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP3A4—Methylprednisolone—psoriatic arthritis	0.114	0.189	CbGbCtD
Dolasetron—CYP3A4—Triamcinolone—psoriatic arthritis	0.0867	0.144	CbGbCtD
Dolasetron—CYP2C9—Dexamethasone—psoriatic arthritis	0.0744	0.123	CbGbCtD
Dolasetron—CYP3A4—Betamethasone—psoriatic arthritis	0.0744	0.123	CbGbCtD
Dolasetron—CYP3A4—Prednisolone—psoriatic arthritis	0.0734	0.122	CbGbCtD
Dolasetron—CYP3A4—Prednisone—psoriatic arthritis	0.0693	0.115	CbGbCtD
Dolasetron—CYP2D6—Dexamethasone—psoriatic arthritis	0.068	0.113	CbGbCtD
Dolasetron—CYP3A4—Dexamethasone—psoriatic arthritis	0.0433	0.0717	CbGbCtD
Dolasetron—Convulsion—Prednisolone—psoriatic arthritis	0.000957	0.00242	CcSEcCtD
Dolasetron—Hypertension—Prednisolone—psoriatic arthritis	0.000954	0.00241	CcSEcCtD
Dolasetron—Arrhythmia—Betamethasone—psoriatic arthritis	0.000946	0.00239	CcSEcCtD
Dolasetron—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000946	0.00239	CcSEcCtD
Dolasetron—Pancreatitis—Methotrexate—psoriatic arthritis	0.000944	0.00238	CcSEcCtD
Dolasetron—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000942	0.00238	CcSEcCtD
Dolasetron—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00094	0.00237	CcSEcCtD
Dolasetron—Bradycardia—Prednisone—psoriatic arthritis	0.000939	0.00237	CcSEcCtD
Dolasetron—Discomfort—Prednisolone—psoriatic arthritis	0.000929	0.00235	CcSEcCtD
Dolasetron—Angioedema—Triamcinolone—psoriatic arthritis	0.000928	0.00234	CcSEcCtD
Dolasetron—Angioedema—Methylprednisolone—psoriatic arthritis	0.000926	0.00234	CcSEcCtD
Dolasetron—Malaise—Triamcinolone—psoriatic arthritis	0.000916	0.00231	CcSEcCtD
Dolasetron—Malaise—Methylprednisolone—psoriatic arthritis	0.000914	0.00231	CcSEcCtD
Dolasetron—Vertigo—Triamcinolone—psoriatic arthritis	0.000913	0.0023	CcSEcCtD
Dolasetron—Syncope—Triamcinolone—psoriatic arthritis	0.000911	0.0023	CcSEcCtD
Dolasetron—Vertigo—Methylprednisolone—psoriatic arthritis	0.000911	0.0023	CcSEcCtD
Dolasetron—Syncope—Methylprednisolone—psoriatic arthritis	0.000909	0.00229	CcSEcCtD
Dolasetron—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000901	0.00228	CcSEcCtD
Dolasetron—Oedema—Prednisolone—psoriatic arthritis	0.000901	0.00228	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—psoriatic arthritis	0.0009	0.00227	CcSEcCtD
Dolasetron—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000893	0.00225	CcSEcCtD
Dolasetron—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000891	0.00225	CcSEcCtD
Dolasetron—Shock—Prednisolone—psoriatic arthritis	0.000887	0.00224	CcSEcCtD
Dolasetron—Cough—Triamcinolone—psoriatic arthritis	0.000886	0.00224	CcSEcCtD
Dolasetron—Convulsion—Triamcinolone—psoriatic arthritis	0.00088	0.00222	CcSEcCtD
Dolasetron—Tachycardia—Prednisolone—psoriatic arthritis	0.00088	0.00222	CcSEcCtD
Dolasetron—Convulsion—Methylprednisolone—psoriatic arthritis	0.000878	0.00222	CcSEcCtD
Dolasetron—Hypertension—Triamcinolone—psoriatic arthritis	0.000877	0.00221	CcSEcCtD
Dolasetron—Hypertension—Methylprednisolone—psoriatic arthritis	0.000875	0.00221	CcSEcCtD
Dolasetron—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000871	0.0022	CcSEcCtD
Dolasetron—Myalgia—Triamcinolone—psoriatic arthritis	0.000865	0.00218	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—psoriatic arthritis	0.000863	0.00218	CcSEcCtD
Dolasetron—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000863	0.00218	CcSEcCtD
Dolasetron—Myalgia—Methylprednisolone—psoriatic arthritis	0.000863	0.00218	CcSEcCtD
Dolasetron—Anxiety—Methylprednisolone—psoriatic arthritis	0.00086	0.00217	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—psoriatic arthritis	0.000858	0.00217	CcSEcCtD
Dolasetron—Flushing—Prednisone—psoriatic arthritis	0.000856	0.00216	CcSEcCtD
Dolasetron—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000855	0.00216	CcSEcCtD
Dolasetron—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000855	0.00216	CcSEcCtD
Dolasetron—Discomfort—Triamcinolone—psoriatic arthritis	0.000854	0.00216	CcSEcCtD
Dolasetron—Discomfort—Methylprednisolone—psoriatic arthritis	0.000853	0.00215	CcSEcCtD
Dolasetron—Dry mouth—Triamcinolone—psoriatic arthritis	0.000846	0.00213	CcSEcCtD
Dolasetron—Angioedema—Betamethasone—psoriatic arthritis	0.000842	0.00213	CcSEcCtD
Dolasetron—Angioedema—Dexamethasone—psoriatic arthritis	0.000842	0.00213	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—psoriatic arthritis	0.000837	0.00211	CcSEcCtD
Dolasetron—Confusional state—Methylprednisolone—psoriatic arthritis	0.000834	0.00211	CcSEcCtD
Dolasetron—Malaise—Dexamethasone—psoriatic arthritis	0.000831	0.0021	CcSEcCtD
Dolasetron—Malaise—Betamethasone—psoriatic arthritis	0.000831	0.0021	CcSEcCtD
Dolasetron—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000829	0.00209	CcSEcCtD
Dolasetron—Oedema—Triamcinolone—psoriatic arthritis	0.000829	0.00209	CcSEcCtD
Dolasetron—Vertigo—Dexamethasone—psoriatic arthritis	0.000828	0.00209	CcSEcCtD
Dolasetron—Vertigo—Betamethasone—psoriatic arthritis	0.000828	0.00209	CcSEcCtD
Dolasetron—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000827	0.00209	CcSEcCtD
Dolasetron—Syncope—Dexamethasone—psoriatic arthritis	0.000827	0.00209	CcSEcCtD
Dolasetron—Syncope—Betamethasone—psoriatic arthritis	0.000827	0.00209	CcSEcCtD
Dolasetron—Arrhythmia—Prednisone—psoriatic arthritis	0.000824	0.00208	CcSEcCtD
Dolasetron—Haematuria—Methotrexate—psoriatic arthritis	0.000818	0.00207	CcSEcCtD
Dolasetron—Shock—Triamcinolone—psoriatic arthritis	0.000816	0.00206	CcSEcCtD
Dolasetron—Shock—Methylprednisolone—psoriatic arthritis	0.000814	0.00205	CcSEcCtD
Dolasetron—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00081	0.00204	CcSEcCtD
Dolasetron—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00081	0.00204	CcSEcCtD
Dolasetron—Epistaxis—Methotrexate—psoriatic arthritis	0.00081	0.00204	CcSEcCtD
Dolasetron—Paraesthesia—Prednisolone—psoriatic arthritis	0.000809	0.00204	CcSEcCtD
Dolasetron—Tachycardia—Triamcinolone—psoriatic arthritis	0.000809	0.00204	CcSEcCtD
Dolasetron—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000807	0.00204	CcSEcCtD
Dolasetron—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000801	0.00202	CcSEcCtD
Dolasetron—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0008	0.00202	CcSEcCtD
Dolasetron—Convulsion—Dexamethasone—psoriatic arthritis	0.000799	0.00202	CcSEcCtD
Dolasetron—Convulsion—Betamethasone—psoriatic arthritis	0.000799	0.00202	CcSEcCtD
Dolasetron—Hypertension—Betamethasone—psoriatic arthritis	0.000796	0.00201	CcSEcCtD
Dolasetron—Hypertension—Dexamethasone—psoriatic arthritis	0.000796	0.00201	CcSEcCtD
Dolasetron—Myalgia—Dexamethasone—psoriatic arthritis	0.000785	0.00198	CcSEcCtD
Dolasetron—Myalgia—Betamethasone—psoriatic arthritis	0.000785	0.00198	CcSEcCtD
Dolasetron—Anxiety—Dexamethasone—psoriatic arthritis	0.000782	0.00197	CcSEcCtD
Dolasetron—Anxiety—Betamethasone—psoriatic arthritis	0.000782	0.00197	CcSEcCtD
Dolasetron—Discomfort—Dexamethasone—psoriatic arthritis	0.000775	0.00196	CcSEcCtD
Dolasetron—Discomfort—Betamethasone—psoriatic arthritis	0.000775	0.00196	CcSEcCtD
Dolasetron—Hypotension—Methylprednisolone—psoriatic arthritis	0.000773	0.00195	CcSEcCtD
Dolasetron—Pain—Prednisolone—psoriatic arthritis	0.000771	0.00195	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000755	0.00191	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000754	0.0019	CcSEcCtD
Dolasetron—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000752	0.0019	CcSEcCtD
Dolasetron—Oedema—Dexamethasone—psoriatic arthritis	0.000752	0.0019	CcSEcCtD
Dolasetron—Oedema—Betamethasone—psoriatic arthritis	0.000752	0.0019	CcSEcCtD
Dolasetron—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000752	0.0019	CcSEcCtD
Dolasetron—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000745	0.00188	CcSEcCtD
Dolasetron—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000744	0.00188	CcSEcCtD
Dolasetron—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000743	0.00188	CcSEcCtD
Dolasetron—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000743	0.00187	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—psoriatic arthritis	0.000743	0.00187	CcSEcCtD
Dolasetron—Anaemia—Prednisone—psoriatic arthritis	0.000742	0.00187	CcSEcCtD
Dolasetron—Shock—Dexamethasone—psoriatic arthritis	0.00074	0.00187	CcSEcCtD
Dolasetron—Shock—Betamethasone—psoriatic arthritis	0.00074	0.00187	CcSEcCtD
Dolasetron—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000739	0.00187	CcSEcCtD
Dolasetron—Agitation—Prednisone—psoriatic arthritis	0.000738	0.00186	CcSEcCtD
Dolasetron—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000736	0.00186	CcSEcCtD
Dolasetron—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000736	0.00186	CcSEcCtD
Dolasetron—Tachycardia—Betamethasone—psoriatic arthritis	0.000734	0.00185	CcSEcCtD
Dolasetron—Tachycardia—Dexamethasone—psoriatic arthritis	0.000734	0.00185	CcSEcCtD
Dolasetron—Angioedema—Prednisone—psoriatic arthritis	0.000733	0.00185	CcSEcCtD
Dolasetron—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00073	0.00184	CcSEcCtD
Dolasetron—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000728	0.00184	CcSEcCtD
Dolasetron—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000727	0.00184	CcSEcCtD
Dolasetron—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000727	0.00184	CcSEcCtD
Dolasetron—Malaise—Prednisone—psoriatic arthritis	0.000724	0.00183	CcSEcCtD
Dolasetron—Vertigo—Prednisone—psoriatic arthritis	0.000721	0.00182	CcSEcCtD
Dolasetron—Syncope—Prednisone—psoriatic arthritis	0.00072	0.00182	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—psoriatic arthritis	0.000718	0.00181	CcSEcCtD
Dolasetron—Anorexia—Dexamethasone—psoriatic arthritis	0.000717	0.00181	CcSEcCtD
Dolasetron—Anorexia—Betamethasone—psoriatic arthritis	0.000717	0.00181	CcSEcCtD
Dolasetron—Urticaria—Prednisolone—psoriatic arthritis	0.000716	0.00181	CcSEcCtD
Dolasetron—Fatigue—Triamcinolone—psoriatic arthritis	0.000715	0.0018	CcSEcCtD
Dolasetron—Fatigue—Methylprednisolone—psoriatic arthritis	0.000713	0.0018	CcSEcCtD
Dolasetron—Pain—Triamcinolone—psoriatic arthritis	0.000709	0.00179	CcSEcCtD
Dolasetron—Loss of consciousness—Prednisone—psoriatic arthritis	0.000705	0.00178	CcSEcCtD
Dolasetron—Hypotension—Dexamethasone—psoriatic arthritis	0.000703	0.00177	CcSEcCtD
Dolasetron—Hypotension—Betamethasone—psoriatic arthritis	0.000703	0.00177	CcSEcCtD
Dolasetron—Convulsion—Prednisone—psoriatic arthritis	0.000695	0.00176	CcSEcCtD
Dolasetron—Hypertension—Prednisone—psoriatic arthritis	0.000693	0.00175	CcSEcCtD
Dolasetron—Chills—Methotrexate—psoriatic arthritis	0.000691	0.00175	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000685	0.00173	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000685	0.00173	CcSEcCtD
Dolasetron—Arthralgia—Prednisone—psoriatic arthritis	0.000683	0.00172	CcSEcCtD
Dolasetron—Myalgia—Prednisone—psoriatic arthritis	0.000683	0.00172	CcSEcCtD
Dolasetron—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000683	0.00172	CcSEcCtD
Dolasetron—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000682	0.00172	CcSEcCtD
Dolasetron—Anxiety—Prednisone—psoriatic arthritis	0.000681	0.00172	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000676	0.00171	CcSEcCtD
Dolasetron—Paraesthesia—Betamethasone—psoriatic arthritis	0.000675	0.00171	CcSEcCtD
Dolasetron—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000675	0.00171	CcSEcCtD
Dolasetron—Discomfort—Prednisone—psoriatic arthritis	0.000675	0.0017	CcSEcCtD
Dolasetron—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000664	0.00168	CcSEcCtD
Dolasetron—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000662	0.00167	CcSEcCtD
Dolasetron—Dyspepsia—Betamethasone—psoriatic arthritis	0.000662	0.00167	CcSEcCtD
Dolasetron—Urticaria—Triamcinolone—psoriatic arthritis	0.000659	0.00166	CcSEcCtD
Dolasetron—Urticaria—Methylprednisolone—psoriatic arthritis	0.000657	0.00166	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—psoriatic arthritis	0.000657	0.00166	CcSEcCtD
Dolasetron—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000655	0.00165	CcSEcCtD
Dolasetron—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000655	0.00165	CcSEcCtD
Dolasetron—Oedema—Prednisone—psoriatic arthritis	0.000655	0.00165	CcSEcCtD
Dolasetron—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000654	0.00165	CcSEcCtD
Dolasetron—Decreased appetite—Betamethasone—psoriatic arthritis	0.000654	0.00165	CcSEcCtD
Dolasetron—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000654	0.00165	CcSEcCtD
Dolasetron—Fatigue—Dexamethasone—psoriatic arthritis	0.000649	0.00164	CcSEcCtD
Dolasetron—Fatigue—Betamethasone—psoriatic arthritis	0.000649	0.00164	CcSEcCtD
Dolasetron—Shock—Prednisone—psoriatic arthritis	0.000644	0.00163	CcSEcCtD
Dolasetron—Pain—Dexamethasone—psoriatic arthritis	0.000643	0.00162	CcSEcCtD
Dolasetron—Pain—Betamethasone—psoriatic arthritis	0.000643	0.00162	CcSEcCtD
Dolasetron—Tachycardia—Prednisone—psoriatic arthritis	0.000639	0.00161	CcSEcCtD
Dolasetron—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000633	0.0016	CcSEcCtD
Dolasetron—Anorexia—Prednisone—psoriatic arthritis	0.000624	0.00158	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000622	0.00157	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—psoriatic arthritis	0.00062	0.00157	CcSEcCtD
Dolasetron—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00062	0.00156	CcSEcCtD
Dolasetron—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00062	0.00156	CcSEcCtD
Dolasetron—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000615	0.00155	CcSEcCtD
Dolasetron—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000615	0.00155	CcSEcCtD
Dolasetron—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000611	0.00154	CcSEcCtD
Dolasetron—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000609	0.00154	CcSEcCtD
Dolasetron—Malaise—Methotrexate—psoriatic arthritis	0.000605	0.00153	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—psoriatic arthritis	0.000603	0.00152	CcSEcCtD
Dolasetron—Urticaria—Dexamethasone—psoriatic arthritis	0.000598	0.00151	CcSEcCtD
Dolasetron—Urticaria—Betamethasone—psoriatic arthritis	0.000598	0.00151	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000597	0.00151	CcSEcCtD
Dolasetron—Dizziness—Prednisolone—psoriatic arthritis	0.000596	0.0015	CcSEcCtD
Dolasetron—Asthenia—Triamcinolone—psoriatic arthritis	0.000595	0.0015	CcSEcCtD
Dolasetron—Body temperature increased—Betamethasone—psoriatic arthritis	0.000595	0.0015	CcSEcCtD
Dolasetron—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000595	0.0015	CcSEcCtD
Dolasetron—Abdominal pain—Betamethasone—psoriatic arthritis	0.000595	0.0015	CcSEcCtD
Dolasetron—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000595	0.0015	CcSEcCtD
Dolasetron—Asthenia—Methylprednisolone—psoriatic arthritis	0.000593	0.0015	CcSEcCtD
Dolasetron—Paraesthesia—Prednisone—psoriatic arthritis	0.000588	0.00148	CcSEcCtD
Dolasetron—Pruritus—Triamcinolone—psoriatic arthritis	0.000587	0.00148	CcSEcCtD
Dolasetron—Cough—Methotrexate—psoriatic arthritis	0.000585	0.00148	CcSEcCtD
Dolasetron—Pruritus—Methylprednisolone—psoriatic arthritis	0.000585	0.00148	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—psoriatic arthritis	0.000581	0.00147	CcSEcCtD
Dolasetron—Dyspepsia—Prednisone—psoriatic arthritis	0.000577	0.00146	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—psoriatic arthritis	0.000571	0.00144	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—psoriatic arthritis	0.000571	0.00144	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—psoriatic arthritis	0.000571	0.00144	CcSEcCtD
Dolasetron—Decreased appetite—Prednisone—psoriatic arthritis	0.000569	0.00144	CcSEcCtD
Dolasetron—Rash—Prednisolone—psoriatic arthritis	0.000568	0.00143	CcSEcCtD
Dolasetron—Dermatitis—Prednisolone—psoriatic arthritis	0.000568	0.00143	CcSEcCtD
Dolasetron—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000566	0.00143	CcSEcCtD
Dolasetron—Fatigue—Prednisone—psoriatic arthritis	0.000565	0.00143	CcSEcCtD
Dolasetron—Headache—Prednisolone—psoriatic arthritis	0.000565	0.00143	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—psoriatic arthritis	0.000564	0.00142	CcSEcCtD
Dolasetron—Constipation—Prednisone—psoriatic arthritis	0.00056	0.00141	CcSEcCtD
Dolasetron—Confusional state—Methotrexate—psoriatic arthritis	0.000552	0.00139	CcSEcCtD
Dolasetron—Dizziness—Triamcinolone—psoriatic arthritis	0.000548	0.00138	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000547	0.00138	CcSEcCtD
Dolasetron—Dizziness—Methylprednisolone—psoriatic arthritis	0.000547	0.00138	CcSEcCtD
Dolasetron—Feeling abnormal—Prednisone—psoriatic arthritis	0.00054	0.00136	CcSEcCtD
Dolasetron—Asthenia—Dexamethasone—psoriatic arthritis	0.00054	0.00136	CcSEcCtD
Dolasetron—Asthenia—Betamethasone—psoriatic arthritis	0.00054	0.00136	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000536	0.00135	CcSEcCtD
Dolasetron—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000536	0.00135	CcSEcCtD
Dolasetron—Pruritus—Betamethasone—psoriatic arthritis	0.000532	0.00134	CcSEcCtD
Dolasetron—Pruritus—Dexamethasone—psoriatic arthritis	0.000532	0.00134	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000529	0.00134	CcSEcCtD
Dolasetron—Rash—Triamcinolone—psoriatic arthritis	0.000523	0.00132	CcSEcCtD
Dolasetron—Dermatitis—Triamcinolone—psoriatic arthritis	0.000522	0.00132	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—psoriatic arthritis	0.000522	0.00132	CcSEcCtD
Dolasetron—Rash—Methylprednisolone—psoriatic arthritis	0.000522	0.00132	CcSEcCtD
Dolasetron—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000521	0.00132	CcSEcCtD
Dolasetron—Urticaria—Prednisone—psoriatic arthritis	0.00052	0.00131	CcSEcCtD
Dolasetron—Headache—Triamcinolone—psoriatic arthritis	0.000519	0.00131	CcSEcCtD
Dolasetron—Headache—Methylprednisolone—psoriatic arthritis	0.000518	0.00131	CcSEcCtD
Dolasetron—Abdominal pain—Prednisone—psoriatic arthritis	0.000518	0.00131	CcSEcCtD
Dolasetron—Body temperature increased—Prednisone—psoriatic arthritis	0.000518	0.00131	CcSEcCtD
Dolasetron—Diarrhoea—Betamethasone—psoriatic arthritis	0.000515	0.0013	CcSEcCtD
Dolasetron—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000515	0.0013	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—psoriatic arthritis	0.000512	0.00129	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000499	0.00126	CcSEcCtD
Dolasetron—Dizziness—Betamethasone—psoriatic arthritis	0.000497	0.00126	CcSEcCtD
Dolasetron—Dizziness—Dexamethasone—psoriatic arthritis	0.000497	0.00126	CcSEcCtD
Dolasetron—Paraesthesia—Methotrexate—psoriatic arthritis	0.000492	0.00124	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—psoriatic arthritis	0.000488	0.00123	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—psoriatic arthritis	0.000487	0.00123	CcSEcCtD
Dolasetron—Hypersensitivity—Prednisone—psoriatic arthritis	0.000483	0.00122	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—psoriatic arthritis	0.000482	0.00122	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—psoriatic arthritis	0.000476	0.0012	CcSEcCtD
Dolasetron—Rash—Dexamethasone—psoriatic arthritis	0.000474	0.0012	CcSEcCtD
Dolasetron—Rash—Betamethasone—psoriatic arthritis	0.000474	0.0012	CcSEcCtD
Dolasetron—Dermatitis—Betamethasone—psoriatic arthritis	0.000474	0.0012	CcSEcCtD
Dolasetron—Dermatitis—Dexamethasone—psoriatic arthritis	0.000474	0.0012	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—psoriatic arthritis	0.000472	0.00119	CcSEcCtD
Dolasetron—Headache—Dexamethasone—psoriatic arthritis	0.000471	0.00119	CcSEcCtD
Dolasetron—Headache—Betamethasone—psoriatic arthritis	0.000471	0.00119	CcSEcCtD
Dolasetron—Asthenia—Prednisone—psoriatic arthritis	0.00047	0.00119	CcSEcCtD
Dolasetron—Pain—Methotrexate—psoriatic arthritis	0.000468	0.00118	CcSEcCtD
Dolasetron—Pruritus—Prednisone—psoriatic arthritis	0.000463	0.00117	CcSEcCtD
Dolasetron—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000451	0.00114	CcSEcCtD
Dolasetron—Diarrhoea—Prednisone—psoriatic arthritis	0.000448	0.00113	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000448	0.00113	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—psoriatic arthritis	0.000435	0.0011	CcSEcCtD
Dolasetron—Dizziness—Prednisone—psoriatic arthritis	0.000433	0.00109	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—psoriatic arthritis	0.000433	0.00109	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—psoriatic arthritis	0.000433	0.00109	CcSEcCtD
Dolasetron—Rash—Prednisone—psoriatic arthritis	0.000413	0.00104	CcSEcCtD
Dolasetron—Dermatitis—Prednisone—psoriatic arthritis	0.000413	0.00104	CcSEcCtD
Dolasetron—Headache—Prednisone—psoriatic arthritis	0.00041	0.00104	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000403	0.00102	CcSEcCtD
Dolasetron—Asthenia—Methotrexate—psoriatic arthritis	0.000393	0.000992	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—psoriatic arthritis	0.000387	0.000978	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—psoriatic arthritis	0.000375	0.000946	CcSEcCtD
Dolasetron—Dizziness—Methotrexate—psoriatic arthritis	0.000362	0.000914	CcSEcCtD
Dolasetron—Rash—Methotrexate—psoriatic arthritis	0.000345	0.000871	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—psoriatic arthritis	0.000345	0.000871	CcSEcCtD
Dolasetron—Headache—Methotrexate—psoriatic arthritis	0.000343	0.000866	CcSEcCtD
